Healthcare Stocks

Fisher & Paykel (NZX:FPH) reports 28% decline in FY22 profit, shares slide

  • May 25, 2022 02:31 PM NZST
  • Sonal
 Fisher & Paykel (NZX:FPH) reports 28% decline in FY22 profit, shares slide

Highlights Fisher & Paykel reported a 28% drop in NPAT in FY22 as demand for its breathing devices slowed globally. FPH’s shares were trading 0.72% lower during the day at $20.56. The Company launched new products and approved a fin...

Read More...
COVID-19 proved a breath of fresh air for Fisher and Paykel, revenue soars

COVID-19 proved a breath of fresh air for Fisher and Paykel, revenue soars

Summary Fisher and Paykel has seen a surge in revenue by 73%. This was made possible due to increased COVID-19-led hospitalisations and need for acute respiratory products. Revises its November projections upwards for revenue and net profits. ...

Read More...
NZX50 listed Retirement Village stocks to be considered in 2021 - Arvida, Summerset, Radius

NZX50 listed Retirement Village stocks to be considered in 2021 - Arvida, Summerset, Radius

Summary Arvida is optimistic that it can deliver and sell more than 450 retirement units in the next two years. In order to kick off its expansion plans across the ditch, Summerset hopes to begin construction in Victoria, Australia, in late 202...

Read More...
Three NZX healthcare stocks to watch out in 2021

Three NZX healthcare stocks to watch out in 2021

Summary Fisher and Paykel healthcare set to grow due to the requirement of hardware for respiratory problems. Ryman Healthcare has ambitious plans of opening six more integrated villages for the elderly. Oceania healthcare set to use proceeds ...

Read More...
What is driving the volatility in Cannasouth (NZX:CBD) stock?

What is driving the volatility in Cannasouth (NZX:CBD) stock?

Summary Cannasouth shares increased by 7% from its last close on 12 January but on 13 January 2021, the shares ended at NZ$0.62 decreasing by 4.62%. Cannasouth stock is highly volatile with an average daily movement of 2.8% for the past 3 month...

Read More...
Here’s why Rua Bioscience Ltd.’s (NZX:RUA) share price is trading high

Here’s why Rua Bioscience Ltd.’s (NZX:RUA) share price is trading high

Rua Bioscience Ltd (NZX:RUA), which got listed on NZX in October 2020, is trading 1.79% up at NZ$ 0.570 on the New Zealand Stock Exchange at the close of the trading session, on Tuesday. The Initial Public Offering (IPO) in October raised NZ$20 mil...

Read More...
TruScreen (NZX:TRU) shares gather momentum after ASX listing, shares up by 35%

TruScreen (NZX:TRU) shares gather momentum after ASX listing, shares up by 35%

Summary TruScreen shares soared by about 35% today after the stock got listed on ASX on 6 January, making it a dual-listed company. The Kiwi cervical cancer screening company made a debut on ASX after raising $2 million in its initial public of...

Read More...
Ryman Healthcare making progress on its plans of adding retirement villages

Ryman Healthcare making progress on its plans of adding retirement villages

Summary Ryman healthcare makes progress on opening 6 villages in Victoria this year. The Company intends to keep its villages COVID-19 free in future. Further, Ryman healthcare plans to have more innovations to improve experience in the villag...

Read More...
A 900% stock price rise in a year! What is the recipe to Pacific Edge’s rally?

A 900% stock price rise in a year! What is the recipe to Pacific Edge’s rally?

S&P/NZX 50 index has surpassed several benchmarks in 2020 by drawing investors, who support homestay strategies that target broader foreign markets. One such stock which has achieved a record high this year is Pacific Edge Limited. Shares of&nbs...

Read More...
AFT Pharmaceuticals ropes in a new director, launches Maxigesic® in Canada  

AFT Pharmaceuticals ropes in a new director, launches Maxigesic® in Canada  

Summary AFT Pharmaceuticals has appointed Canada-based Dr Ted Witek as its Independent Director to help the company’s Canadian market grow. The Company has also introduced Maxigesic tablets for pain relief in Canada, which further indicat...

Read More...
NZ gets a shot in the arm with 10.7M Novavax COVID-19 vaccines

NZ gets a shot in the arm with 10.7M Novavax COVID-19 vaccines

Encouraging developments on the vaccine front have ignited confidence and optimism around the world, with a feeling that the pandemic is nearing its end. But how much time will it take to cease to exist, remains a question? Novavax, Inc. (NASDAQ:NVA...

Read More...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK